Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a new distributor agreement in Qatar. The agreement with Ali Bin Ali Medical (ABAM) will give the Qatar healthcare industry access to the Zimmer Biomet’s advanced technologies, surgical robotics and implants.
“It’s a transformative period in healthcare and the continued growth of Zimmer Biomet’s presence in the Middle East means we can help to alleviate pain and improve the quality of life for even more people – and that is our ultimate mission,” said Farah Hamdan, Zimmer Biomet General Manager, Middle East North Africa and Turkey.
“As part of Ali Bin Ali Medical’s vision to provide the best products and services to the healthcare sector in Qatar, ABAM is proud to reinforce its leadership in the marketplace and strengthen its presence through partnering with Zimmer Biomet,” said Monzer Abdel Samad, General Manager, ABAM.
Zimmer Biomet and ABAM will together serve the Qatari market, providing industry-leading solutions to customers and helping to improve patient outcomes. The MENAT region continues to be an important customer base for Zimmer Biomet, with a significant uptick in interest and adoption of its healthcare technologies over the past 10 years.
About the Company
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit zimmerbiomet.com or follow Zimmer Biomet on Twitter at twitter.com/zimmerbiomet.
